GILLIS STEVEN
Insider CIK 1229592 · BLUE Director · TAK Director · PZRX Director, 10% owner · PULM Director · SNNA 10% owner · CDAK Director · FIXX Director · ERAS 10% owner · SANA 10% owner · BOLD 10% owner · LYEL 10% owner · VERV 10% owner · DALS 10% owner · NMRA 10% owner · PRME 10% owner · RAPP 10% owner · MTSR Director, 10% owner · SPTX 10% owner · KARD Director, 10% owner · ASPE 10% owner · CTY 10% owner · VBIV Director, 10% owner · VBIV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 214,355 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 259,948 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion deriv | 2026-11-02 | 2026-11-02 | 187,182 | — | — | 0 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 1,200,000 | $15.00 | $18.00M | 1,200,000 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 214,355 | — | — | 1,161,074 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 946,719 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 651,229 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 364,925 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 66,667 | $15.00 | $1.00M | 66,667 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 259,948 | — | — | 1,393,848 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 295,490 | — | — | 1,133,900 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 286,304 | — | — | 838,410 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 298,258 | — | — | 552,106 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | C Conversion | 2026-11-02 | 2026-11-02 | 187,182 | — | — | 253,848 | SEC↗ |
| ASPE Aspen Neuroscience, Inc. | P Buy | 2026-11-02 | 2026-11-02 | 66,666 | $15.00 | $1000.0K | 66,666 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 1,845,585 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 4,991,633 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion deriv | 2026-10-19 | 2026-10-19 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | P Buy | 2026-10-19 | 2026-10-19 | 170,000 | $18.00 | $3.06M | 13,692,507 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 2,027,006 | — | — | 13,522,507 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 5,482,309 | — | — | 11,495,501 | SEC↗ |
| CTY CITY THERAPEUTICS, INC. | C Conversion | 2026-10-19 | 2026-10-19 | 3,294,900 | — | — | 6,013,192 | SEC↗ |
| TAK TAKEDA PHARMACEUTICAL CO L | D To issuer deriv | 2026-07-10 | 2026-07-06 | 1,152 | $4931.20 | $5.68M | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise deriv | 2026-07-01 | 2026-07-06 | 16,000 | — | $0 | 0 | SEC↗ |
| TAK TAKEDA PHARMACEUTICAL CO L | A Award deriv | 2026-07-01 | 2026-07-06 | 1,319 | — | $0 | 1,319 | SEC↗ |
| BOLD Boundless Bio, Inc. | S Sale | 2026-07-01 | 2026-07-06 | 16,000 | $2.49 | $39.8K | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | M Exercise | 2026-07-01 | 2026-07-06 | 16,000 | $1.03 | $16.5K | 16,000 | SEC↗ |
| TAK TAKEDA PHARMACEUTICAL CO L | A Award | 2026-07-01 | 2026-07-06 | 3,800 | — | $0 | 10,400 | SEC↗ |
| KARD Kardigan, Inc. | P Buy | 2026-06-22 | 2026-06-24 | 1,250,000 | $16.00 | $20.00M | 15,042,035 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,204,000 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 5,148,587 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,306,401 | — | $0 | 0 | SEC↗ |
| KARD Kardigan, Inc. | C Conversion | 2026-06-17 | 2026-06-22 | 13,792,035 | — | $0 | 13,792,035 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,513,686 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion deriv | 2026-05-04 | 2026-05-04 | 2,681,265 | — | $0 | 0 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 2,513,686 | — | $0 | 2,513,686 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | C Conversion | 2026-05-04 | 2026-05-04 | 2,681,265 | — | $0 | 5,194,951 | SEC↗ |
| SPTX Seaport Therapeutics, Inc. | P Buy | 2026-05-04 | 2026-05-04 | 1,100,000 | $18.00 | $19.80M | 6,294,951 | SEC↗ |
| LYEL Lyell Immunopharma, Inc. | P Buy | 2026-03-06 | 2026-03-09 | 488,090 | $25.61 | $12.50M | 1,426,528 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-14 | 18,503,128 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | D To issuer | 2025-11-13 | 2025-11-14 | 8,313,680 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2025-10-27 | 2025-10-29 | 1,915,700 | $2.61 | $5.00M | 6,046,907 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2025-08-01 | 2025-08-01 | 3,030,300 | $3.30 | $10.00M | 6,230,300 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 19,933,333 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 15,000,000 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion deriv | 2025-02-03 | 2025-02-03 | 2,678,571 | — | $0 | 0 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 7,523,682 | — | $0 | 7,523,682 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 1,432,224 | $18.00 | $25.78M | 18,503,128 | SEC↗ |
| MTSR Metsera, Inc. | P Buy | 2025-02-03 | 2025-02-03 | 789,998 | $18.00 | $14.22M | 8,313,680 | SEC↗ |
| MTSR Metsera, Inc. | C Conversion | 2025-02-03 | 2025-02-03 | 16,006,949 | — | $0 | 17,070,904 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 20,000,000 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion deriv | 2024-06-10 | 2024-06-10 | 11,924,138 | — | $0 | 0 | SEC↗ |
| RAPP Rapport Therapeutics, Inc. | C Conversion | 2024-06-10 | 2024-06-10 | 3,728,738 | — | $0 | 3,728,738 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 424,908 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 586,080 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 454,212 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 227,920 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 164,835 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 201,465 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion deriv | 2024-04-02 | 2024-04-04 | 366,301 | — | $0 | 0 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 66,667 | $16.00 | $1.07M | 683,759 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 1,048,433 | — | $0 | 1,048,433 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 787,545 | — | $0 | 828,570 | SEC↗ |
| BOLD Boundless Bio, Inc. | C Conversion | 2024-04-02 | 2024-04-04 | 589,743 | — | $0 | 617,092 | SEC↗ |
| BOLD Boundless Bio, Inc. | P Buy | 2024-04-02 | 2024-04-04 | 133,333 | $16.00 | $2.13M | 1,181,766 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2024-02-15 | 2024-02-20 | 3,200,000 | $6.25 | $20.00M | 3,200,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 363,637 | $5.50 | $2.00M | 10,667,387 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| SANA Sana Biotechnology, Inc. | P Buy | 2024-02-08 | 2024-02-12 | 727,272 | $5.50 | $4.00M | 12,446,022 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 1,176,593 | — | $0 | 2,321,566 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | J Other | 2023-12-08 | 2023-12-12 | 703,061 | — | $0 | 1,387,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-14 | 2023-11-15 | 3,357 | $11.98 | $40.2K | 4,131,207 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-13 | 2023-11-15 | 31,653 | $11.75 | $371.9K | 4,127,850 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 5,431 | $11.75 | $63.8K | 4,096,197 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-10 | 2023-11-13 | 11,844 | $11.37 | $134.7K | 4,090,766 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-09 | 2023-11-13 | 31,079 | $10.53 | $327.3K | 4,078,922 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-08 | 2023-11-13 | 69,127 | $10.78 | $745.2K | 4,024,719 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-08 | 2023-11-13 | 23,124 | $11.79 | $272.6K | 4,047,843 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-07 | 2023-11-07 | 30,192 | $11.50 | $347.2K | 3,955,592 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-06 | 2023-11-07 | 43,082 | $11.55 | $497.6K | 3,925,400 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-11-03 | 2023-11-07 | 22,420 | $11.38 | $255.1K | 3,882,318 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-29 | 2023-09-29 | 34,560 | $13.98 | $483.1K | 3,859,898 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-28 | 2023-09-29 | 25,110 | $13.69 | $343.8K | 3,825,338 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-28 | 2023-09-29 | 16,841 | $13.06 | $219.9K | 3,800,228 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-27 | 2023-09-27 | 24,504 | $12.31 | $301.6K | 3,783,387 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-26 | 2023-09-27 | 34,000 | $11.73 | $398.8K | 3,758,883 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 29,967 | $11.65 | $349.1K | 3,724,883 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-25 | 2023-09-25 | 30,773 | $10.80 | $332.3K | 3,694,916 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-22 | 2023-09-25 | 40,000 | $11.14 | $445.6K | 3,664,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion deriv | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 0 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | P Buy | 2023-09-19 | 2023-09-20 | 1,500,000 | $17.00 | $25.50M | 3,624,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 684,167 | — | $0 | 684,167 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 1,144,973 | — | $0 | 1,144,973 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,895,021 | — | $0 | 12,205,379 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 2,124,143 | — | $0 | 2,124,143 | SEC↗ |
| NMRA Neumora Therapeutics, Inc. | C Conversion | 2023-09-19 | 2023-09-20 | 6,576,400 | — | $0 | 11,886,758 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2023-07-28 | 2023-08-10 | 1,600,000 | — | $0 | 0 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2023-07-27 | 2023-07-28 | 52,500 | — | $0 | 52,500 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy deriv | 2023-07-10 | 2023-07-18 | 609,090 | — | $0 | 609,090 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2023-07-10 | 2023-07-18 | 609,090 | $1.65 | $1.00M | 1,043,292 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2023-06-14 | 2023-06-15 | 23,000 | — | $0 | 23,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise deriv | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | M Exercise | 2023-02-16 | 2023-02-21 | 8,750 | — | $0 | 8,750 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2023-01-26 | 2023-01-30 | 75,000 | — | $0 | 75,000 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 1,141,474 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 16,666,667 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 16,666,664 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion deriv | 2022-10-24 | 2022-10-26 | 1,141,474 | — | $0 | 0 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 6,128,297 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 5,728,297 | — | $0 | 5,728,297 | SEC↗ |
| PRME Prime Medicine, Inc. | C Conversion | 2022-10-24 | 2022-10-26 | 5,728,297 | — | $0 | 5,728,297 | SEC↗ |
| PRME Prime Medicine, Inc. | P Buy | 2022-10-24 | 2022-10-26 | 400,000 | $17.00 | $6.80M | 6,128,297 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy deriv | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 5,000,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2022-09-13 | 2022-09-15 | 5,000,000 | — | $0 | 7,503,903 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 7,500 | — | $0 | 7,500 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-06-17 | 2022-06-21 | 1,500 | — | $0 | 1,500 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2022-06-15 | 2022-06-17 | 18,000 | — | $0 | 18,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2022-02-16 | 2022-02-18 | 8,750 | — | $0 | 8,750 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2022-01-27 | 2022-01-31 | 100,000 | — | $0 | 100,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other deriv | 2021-08-05 | 2021-08-09 | 701,250 | — | $0 | 4,465,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | J Other | 2021-07-30 | 2021-08-03 | 650,000 | $10.00 | $6.50M | 2,250,000 | SEC↗ |
| DALS DA32 Life Science Tech Acq | P Buy | 2021-07-30 | 2021-08-03 | 1,600,000 | $10.00 | $16.00M | 1,600,000 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 2,100,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 2,100,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 3,400,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,133,333 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 3,400,000 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion deriv | 2021-07-20 | 2021-07-20 | 1,133,333 | — | $0 | 0 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 5,527,777 | — | $0 | 5,527,777 | SEC↗ |
| ERAS Erasca, Inc. | C Conversion | 2021-07-20 | 2021-07-20 | 5,527,777 | — | $0 | 5,527,777 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 7,107,024 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 7,107,023 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 4,508,144 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion deriv | 2021-06-21 | 2021-06-23 | 4,508,146 | — | $0 | 0 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 1,254,404 | — | $0 | 1,254,404 | SEC↗ |
| VERV Verve Therapeutics, Inc. | C Conversion | 2021-06-21 | 2021-06-23 | 1,254,405 | — | $0 | 1,254,405 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2021-06-18 | 2021-06-22 | 10,000 | — | $0 | 10,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2021-06-17 | 2021-06-22 | 18,000 | — | $0 | 18,000 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 2,343,750 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 781,250 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 9,375,000 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 5,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion deriv | 2021-02-08 | 2021-02-10 | 3,687,500 | — | $0 | 0 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,303,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 11,718,750 | — | $0 | 11,718,750 | SEC↗ |
| SANA Sana Biotechnology, Inc. | C Conversion | 2021-02-08 | 2021-02-10 | 10,156,250 | — | $0 | 10,301,250 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2021-01-27 | 2021-01-29 | 100,000 | — | $0 | 100,000 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 3,000,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion deriv | 2020-10-16 | 2020-10-20 | 13,950,000 | — | $0 | 0 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | P Buy | 2020-10-16 | 2020-10-20 | 235,000 | $15.00 | $3.52M | 2,503,903 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 1,784,572 | — | $0 | 1,848,535 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | C Conversion | 2020-10-16 | 2020-10-20 | 420,368 | — | $0 | 2,268,903 | SEC↗ |
| CDAK Codiak BioSciences, Inc. | A Award deriv | 2020-10-13 | 2020-10-15 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 1,771 | — | $0 | 1,771 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 1,771 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 880 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 111 | — | $0 | 111 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 111 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 880 | — | $0 | 880 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 440 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 440 | — | $0 | 440 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 12,400 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 12,400 | — | $0 | 12,400 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 15,000 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 10,000 | — | $0 | 10,000 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 10,000 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PULM Pulmatrix, Inc. | D To issuer deriv | 2020-08-28 | 2020-09-01 | 15,000 | — | $0 | 0 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-08-28 | 2020-09-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2020-06-10 | 2020-06-12 | 18,000 | — | $0 | 18,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-04-02 | 2020-04-06 | 10,000 | — | $0 | 10,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2020-01-22 | 2020-01-24 | 350,000 | — | $0 | 350,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2020-01-09 | 2020-01-13 | 15,000 | — | $0 | 15,000 | SEC↗ |
| VBIV VBI VACCINES INC. | P Buy | 2019-09-19 | 2019-09-23 | 10,000,000 | $0.50 | $5.00M | 13,026,057 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise deriv | 2019-06-14 | 2019-06-18 | 18,750 | — | $0 | 0 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise | 2019-06-14 | 2019-06-18 | 18,750 | — | $0 | 84,416 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2019-06-06 | 2019-06-10 | 15,580 | — | $0 | 15,580 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2019-05-16 | 2019-05-20 | 15,000 | — | $0 | 15,000 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 2,900,575 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 1,865,800 | $2.50 | $4.66M | 1,865,800 | SEC↗ |
| SNNA Sienna Biopharmaceuticals, | P Buy | 2019-02-22 | 2019-02-26 | 150,000 | $2.50 | $375.0K | 1,032,493 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2019-01-31 | 2019-02-04 | 300,000 | — | $0 | 300,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise deriv | 2018-06-14 | 2018-06-25 | 18,750 | — | $0 | 18,750 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise | 2018-06-14 | 2018-06-25 | 18,750 | — | $0 | 65,666 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2018-06-05 | 2018-06-06 | 124,000 | — | $0 | 124,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 1,150,000 | — | $0 | 1,150,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy deriv | 2018-04-03 | 2018-04-05 | 1,150,000 | — | $0 | 1,150,000 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy | 2018-04-03 | 2018-04-05 | 1,150,000 | — | $0 | 3,436,456 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 4,683,238 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion deriv | 2018-04-02 | 2018-04-04 | 1,385,457 | — | $0 | 0 | SEC↗ |
| FIXX Homology Medicines, Inc. | C Conversion | 2018-04-02 | 2018-04-04 | 6,068,695 | — | $0 | 6,068,695 | SEC↗ |
| FIXX Homology Medicines, Inc. | A Award deriv | 2018-03-27 | 2018-03-29 | 31,160 | — | $0 | 31,160 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2018-01-23 | 2018-01-25 | 100,000 | — | $0 | 100,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | P Buy | 2017-10-30 | 2017-10-31 | 300,000 | $3.05 | $915.0K | 3,026,057 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise deriv | 2017-06-14 | 2017-06-16 | 18,750 | — | $0 | 37,500 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise | 2017-06-14 | 2017-06-16 | 18,750 | — | $0 | 46,916 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2017-05-25 | 2017-05-30 | 14,000 | — | $0 | 14,000 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | A Award deriv | 2017-03-29 | 2017-03-31 | 15,000 | — | $0 | 15,000 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2017-03-20 | 2017-03-22 | 4,400 | — | $0 | 4,400 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise deriv | 2017-01-17 | 2017-03-31 | 6,377 | $2.50 | $15.9K | 0 | SEC↗ |
| VBIV VBI Vaccines Inc/BC | M Exercise | 2017-01-17 | 2017-03-31 | 6,377 | $2.50 | $15.9K | 28,166 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2016-06-01 | 2016-06-02 | 31,023 | — | $0 | 31,023 | SEC↗ |
| PZRX PHASERX, INC. | A Award deriv | 2016-05-23 | 2016-05-25 | 9,385 | — | $0 | 9,385 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-25 | 195,156 | $0.01 | $2.0K | 1,854,222 | SEC↗ |
| PZRX PHASERX, INC. | P Buy | 2016-05-23 | 2016-05-25 | 1,000,000 | $5.00 | $5.00M | 2,854,222 | SEC↗ |
| PZRX PHASERX, INC. | S Sale | 2016-05-23 | 2016-05-25 | 484,903 | $0.01 | $4.8K | 2,049,378 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2016-02-03 | 2016-02-25 | 8,800 | — | $0 | 8,800 | SEC↗ |
| VBIV VBI VACCINES INC. | A Award | 2015-08-13 | 2015-08-17 | 650,000 | $2.10 | $1.36M | 4,047,830 | SEC↗ |
| VBIV VBI VACCINES INC. | A Award deriv | 2015-07-30 | 2015-08-05 | 70,000 | — | $0 | 191,089 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-07-28 | 2015-07-30 | 5,126 | — | $0 | 18,633 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-07-28 | 2015-07-30 | 233,000 | — | $0 | 90,675 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-06-25 | 2015-06-29 | 11,837 | — | $0 | 13,507 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-06-25 | 2015-06-29 | 538,076 | — | $0 | 323,675 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-24 | 2015-06-25 | 1,108 | — | $0 | 1,108 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-16 | 2015-06-17 | 17,710 | — | $0 | 17,710 | SEC↗ |
| PULM Pulmatrix, Inc. | P Buy | 2015-06-16 | 2015-06-17 | 72,750 | $6.88 | $500.5K | 2,286,456 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-15 | 2015-06-17 | 797,506 | — | $0 | 797,506 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award deriv | 2015-06-15 | 2015-06-25 | 797,506 | — | $0 | 797,506 | SEC↗ |
| PULM Pulmatrix, Inc. | A Award | 2015-06-15 | 2015-06-17 | 2,213,706 | — | $0 | 2,213,706 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2015-06-04 | 2015-06-08 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-01-30 | 2015-02-03 | 179,360 | — | $0 | 861,751 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2015-01-30 | 2015-02-03 | 448 | — | $0 | 1,670 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-10-09 | 2014-10-14 | 115,000 | $35.25 | $4.05M | 1,041,111 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-10-07 | 2014-10-07 | 6,700 | $35.15 | $235.5K | 1,156,111 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-10-06 | 2014-10-07 | 24,100 | $35.16 | $847.4K | 1,162,811 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-10-03 | 2014-10-07 | 26,635 | $35.74 | $951.9K | 1,186,911 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-10-02 | 2014-10-02 | 47,554 | $34.87 | $1.66M | 1,213,546 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-10-01 | 2014-10-02 | 11,516 | $34.75 | $400.2K | 1,261,100 | SEC↗ |
| BLUE bluebird bio, Inc. | S Sale | 2014-09-30 | 2014-10-02 | 32,095 | $36.08 | $1.16M | 1,272,616 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-09-08 | 2014-09-10 | 313,877 | — | $0 | 1,304,711 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-09-08 | 2014-09-10 | 785 | — | $0 | 1,222 | SEC↗ |
| BLUE bluebird bio, Inc. | A Award deriv | 2014-06-11 | 2014-06-12 | 7,500 | — | $0 | 7,500 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-01-23 | 2014-01-24 | 437 | — | $0 | 437 | SEC↗ |
| BLUE bluebird bio, Inc. | J Other | 2014-01-23 | 2014-01-24 | 175,000 | — | $0 | 1,618,588 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 19,971,242 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion deriv | 2013-06-24 | 2013-06-26 | 14,047,762 | — | $0 | 0 | SEC↗ |
| BLUE bluebird bio, Inc. | C Conversion | 2013-06-24 | 2013-06-26 | 1,793,588 | — | $0 | 1,793,588 | SEC↗ |